|Previous Section||Index||Home Page|
Mark Simmonds: To ask the Secretary of State for Health pursuant to the answer of 30 January 2008, Official Report, columns 464-6W, what his estimate is of the costs of (a) community rehabilitation and care, (b) additional monitoring and treatment, (c) ambulatory care and (d) programme management and monitoring in each of the next five financial years. 
Ann Keen: The estimated costs of community rehabilitation and care, additional monitoring and treatment, ambulatory care and programme management and monitoring for the next five financial years are in the following table. Estimated costs for additional monitoring and treatment and ambulatory care are not available separately as the additional treatment may occur in a number of non-inpatient settings including ambulatory care.
|Community rehabilitation and care||Additional monitoring, treatment and ambulatory care||Programme management and monitoring|
Mr. David Jones: To ask the Secretary of State for Health what steps his Department is taking to encourage collaboration between specialist centres in England and Welsh local health boards to improve levels of treatment in England for patients resident in Wales diagnosed with neuromuscular disorders. 
It is the responsibility of Welsh local health boards to commission services to meet the needs of their local population living with neuromuscular disorders. This can include the commissioning, and funding, of diagnosis and treatment at specialist neuromuscular centres in England if deemed appropriate.
Mr. Lansley: To ask the Secretary of State for Health what estimate he has made of the (a) number and (b) cost of finished consultant episodes of treatment given to citizens of other European Economic Area member states in the UK in 2006-07. 
Data from Leeds Primary Care Trust, who collect data from national health service trusts on the number of overseas visitors to the United Kingdom from bilateral health care agreement countries, show that in 2006-07, 5,766 European Economic Area
(EEA) citizens were treated on the NHS of which 5,033 were visitors and 733 were referrals. Cost of treatment totalled £15,051,634 of which £10,585,167 was for visitors and £4,466,467 was for referrals. The way in which the NHS collects this data means that they cannot be broken down by consultant episode.
However, those EEA citizens who are in the UK on a more long term basis, for example to work or to study, or because they are now ordinarily resident in the UK, are not included. Successive Governments have not required the NHS to provide these statistics.
Mr. Lansley: To ask the Secretary of State for Health what estimate he has made of the number of (a) citizens of other European Economic Area (EEA) member states who received health treatment in the UK and (b) UK citizens who received health treatment in other EEA member states in 2006-07 under reciprocal health care arrangements. 
Dawn Primarolo: Data from Leeds PCT who collect data from national health service trusts on the number of overseas visitors to the United Kingdom show that in 2006-07, 5,766 European Economic Area (EEA) citizens were treated on the NHS of which 5,033 were visitors and 733 were referrals.
In 2006-07 the UK was competent for the health care of approximately 164,000 pensioners living in other EEA member states. Due to the scale of the total claims that the UK received and because of the nature of the bilateral agreements that the UK has with some EEA countries, we do not have accurate figures of the total number of UK citizens treated in other EEA member states.
Mr. Lansley: To ask the Secretary of State for Health (1) pursuant to the answer of 7 January 2008, Official Report, column 108W, on health services: standards, if he will place in the Library a copy of the presentation given by Tricia Cable of the Yorkshire and Humber Strategic Health Authority at the meeting of 5 June 2007; 
(2) on what clinical evidence his Department based its decision that the 18 week referral to treatment target would only apply to 95 per cent. of non-admitted patients and 90 per cent. of admitted patients; 
The operational standards for 18 weeks are based on evidence from studies of over 3,000 patient pathways and over 3,700 out-patient bookings. In addition to gathering evidence on clinically complex cases, these studies looked into the impact of patient choice and co-operation on patient pathways.
Mr. Stewart Jackson: To ask the Secretary of State for Health when he plans to make an announcement on new hospital provision serving the Thames Gateway area; and if he will make a statement. 
Mr. Bradshaw: Primary care trusts (PCTs) in the Thames Gateway area are responsible for commissioning health services for existing and new populations in the region. It is for the local health economy (national health service trusts, PCTs and strategic health authorities) to develop proposals and present business cases with value for money and affordable solutions for new hospital and primary care facilities.
More generally, the Governments plans for investment in the Thames Gateway were published in November 2007 by the Department for Communities and Local Government in Thames Gateway: The Delivery Plan. Chapter three, Quality of Life, refers to investment in health care and sets out details of the hospital and primary care facilities either already completed or due to open by 2010-11.
Mike Penning: To ask the Secretary of State for Health (1) what intended savings are expected to result from the review of Part IX of the Drug Tariff; what the costs to date of the review have been; and what savings have been achieved by the current price freeze on Part IX products; 
(2) what the cost of consultations relating to Part IX of the Drug Tariff was in (a) 2005, (b) 2006 and (c) 2007; and how much was spent in each year on consultancy work relating to the consultations. 
Dawn Primarolo: The review of part IX of the Drug Tariff is ongoing, but in the last consultation entitled Arrangements under Part IX of the Drug Tariff for the provision of stoma and incontinence appliances - and related services - to Primary Care. Revised Proposals, which was published in September 2007, proposed options regarding the reimbursement for item price that would reduce reimbursement for the cost of appliances to the national health service by £25 million.
Phase 1, which addressed dressings and reagents, concluded in October 2006 and provided savings of £24 million per year for primary care. The cost for this phase of activity was £1.3 million (excluding VAT); and
Phase 2, which is addressing stoma and urology, has cost £0.8 million (excluding VAT) to date.
The agreement that allows companies to seek price increases related to products listed in part IX of the Drug Tariff expired in April 2006. Therefore, the application for price increases related to the current part IX consultation for products contained in parts A, B and C has been suspended. It has been estimated that the value of this suspension to date is £14.1 million between April 2006 and November 2007.
Mike Penning: To ask the Secretary of State for Health for what reason an impact assessment was not produced alongside the public consultation on changes to Part IX of the Drug Tariff; and if he will make a statement. 
Dawn Primarolo: Two partial regulatory impact assessments have been published alongside the public consultation on proposed new arrangements under Part IX of the Drug Tariff for the provision of stoma and incontinence appliances in primary care: one in October 2005 and November 2006. Copies of these are available in the Library. At the time the Department felt there was no material difference between the consultations which started in September 2007 and November 2006 and decided that the previous partial impact assessments would be sufficient.
Mr. Lansley: To ask the Secretary of State for Health what percentage of midwifery graduates started working as midwives in the NHS within six months of graduation in each of the last five financial years. 
Ann Keen: The percentage of midwifery graduates who started working as midwives in the national health service within six months of graduation is not collected. However the annual work force census on 31 September 2006 showed there were 24,469 qualified midwives working in the NHS in England an increase of 2,084 (9 per cent.) since 1997.
Ann Keen: The number of midwives that were employed in each strategic health authority and national health service trust as of 30 September each year since 1997 has been placed in the Library. The NHS workforce census does not break the figures down by pay band.
|Next Section||Index||Home Page|